Suppr超能文献

睾酮联合度他雄胺而非阿那曲唑可改善年轻肥胖男性的胰岛素敏感性:一项随机对照试验。

Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.

机构信息

Department of Medicine, VA San Diego Healthcare System, San Diego, CA, USA; University of California, San Diego, CA, USA.

出版信息

J Sex Med. 2014 Feb;11(2):563-73. doi: 10.1111/jsm.12368. Epub 2013 Nov 6.

Abstract

INTRODUCTION

Testosterone (T) administration to men increases T, estradiol (E2), dihydrotestosterone (DHT), and fat-free mass (FFM), and decreases fat mass (FM) but does not consistently improve insulin sensitivity (IS).

AIM

The aim of this study was to examine the effects of T administration in obese, nondiabetic men on body composition and IS, and to determine if inhibition (i) of metabolism of T to E2 with anastrazole or to DHT with dutasteride alters these effects.

METHODS

This was a 98-day randomized, double-blind, parallel group, placebo-controlled trial of 57 men, 24-51 year, free T in the lower 25% of normal range (<0.33 nmol/L), body mass index ≥ 30.0 kg/m(2). Subjects were randomized to one of four groups: (i) placebo: gel, pills, and injection; (ii) T/DHT/iE2: T gel, anastrazole, and acyline (gonadotropin releasing-hormone antagonist to suppress endogenous T); (iii) T/iDHT/E2: T gel, dutasteride, and acyline; (iv) T/DHT/E2: T gel, placebo pills, and acyline.

MAIN OUTCOME MEASURES

Main outcome measures are insulin sensitivity as percent change (%Δ) in glucose disposal rates (GDR) from a two-step euglycemic clamp (GDR1 and 2), and %FM and %FFM by dual X-ray absorptiometry scan.

RESULTS

Insulin Sensitivity: %Δ GDR1 differed across groups (P = 0.02, anova) and was significantly higher in the dutasteride (T/iDHT/E2) compared with the placebo and T gel (T/DHT/E2) groups. %ΔGDR2 was higher in the dutasteride (T/iDHT/E2) compared with the anastrazole (T/DHT/iE2) group. Body Composition: T gel alone (T/DHT/E2) or with dutasteride (T/iDHT/E2) significantly increased %FFM (P < 0.05) and decreased %FM (P < 0.05). There was no change in %FFM or %FM after placebo or anastrazole (T/DHT/iE2).

CONCLUSIONS

The combination of T plus dutasteride improved body composition and IS while T alone improved body composition but not IS, suggesting that when T is administered to men, reduction to DHT attenuates the beneficial effects of aromatization to E2 on IS but not body composition.

摘要

简介

给予男性睾丸酮(T)会增加 T、雌二醇(E2)、二氢睾丸酮(DHT)和去脂体重(FFM),减少脂肪量(FM),但并不总能改善胰岛素敏感性(IS)。

目的

本研究旨在探讨睾丸酮在肥胖、非糖尿病男性中的应用对身体成分和 IS 的影响,并确定 T 向 E2 的代谢抑制(用阿那曲唑)或向 DHT 的代谢抑制(用度他雄胺)是否会改变这些作用。

方法

这是一项为期 98 天的随机、双盲、平行分组、安慰剂对照试验,共纳入 57 名年龄在 24-51 岁、游离 T 在正常范围下限的 25%以下(<0.33nmol/L)、体重指数(BMI)≥30.0kg/m2 的男性。受试者随机分为四组:(i)安慰剂组:凝胶、药丸和注射剂;(ii)T/DHT/iE2 组:睾丸酮凝胶、阿那曲唑和 acyline(促性腺激素释放激素拮抗剂,抑制内源性 T);(iii)T/iDHT/E2 组:睾丸酮凝胶、度他雄胺和 acyline;(iv)T/DHT/E2 组:睾丸酮凝胶、安慰剂药丸和 acyline。

主要观察指标

主要观察指标是通过两步血糖钳夹试验(GDR1 和 2)得到的葡萄糖摄取率(GDR)的百分比变化(%Δ),以及双能 X 线吸收法扫描得到的去脂体重(FFM)和脂肪量(FM)的百分比变化。

结果

胰岛素敏感性:各组间%ΔGDR1 存在差异(P=0.02,方差分析),且 dutasteride(T/iDHT/E2)组明显高于安慰剂组和 T 凝胶(T/DHT/E2)组。%ΔGDR2 在 dutasteride(T/iDHT/E2)组高于 anastrazole(T/DHT/iE2)组。身体成分:单独使用 T 凝胶(T/DHT/E2)或与度他雄胺(T/iDHT/E2)合用可显著增加 FFM(P<0.05)和减少 FM(P<0.05)。安慰剂或 anastrazole(T/DHT/iE2)组的 FFM 和 FM 百分比均无变化。

结论

T 加度他雄胺联合治疗可改善身体成分和 IS,而 T 单独治疗仅改善身体成分而不改善 IS,这表明当给予男性 T 时,向 DHT 的转化减少会削弱芳香化向 E2 的转化对 IS 的有益作用,但不会改变身体成分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验